1. Adherence to EASL antibiotic treatment recommendations improves the outcomes of patients with cirrhosis and bacterial infections. Results from the ICA "Global Study". Issue 1 (February 2018) Authors: Piano, S.; Singh, V.; Caraceni, P.; Maiwall, R.; Alessandria, C.; Fernandez, J.; Soares, E.C.; Kim, D.J.; Kim, S.E.; Marino, M.; Vorobioff, J.; Barea, R. Ribeiro; Merli, M.; Elkrief, L.; Vargas, V.; Krag, A.; Singh, S.P.; Lesmana, L.A.; Toledo, C.; Marciano, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adherence to Surviving Sepsis campaign 3-hour bundles improves survival in non-critically ill patients with cirrhosis and sepsis. (February 2020) Authors: Piano, S.; Torresan, L.; Incicco, S.; Tonon, M.; Gambino, C.; Fasolato, S.; Cillo, U.; Burra, P.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of Sepsis-3 criteria in patients with cirrhosis and bacterial infections. Issue 1 (16th February 2017) Authors: Piano, S.; Chies, G.; Tonon, M.; Romano, A.; Vettore, E.; Stanco, M.; Pilutti, C.; Brocca, A.; Fasolato, S.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Calibration of the photon spectrometer PHOS of the ALICE experiment. (28th May 2019) Authors: Acharya, S.; Acosta, F.T.-.; Adamová, D.; Adhya, S.P.; Adler, A.; Adolfsson, J.; Aggarwal, M.M.; Rinella, G. Aglieri; Agnello, M.; Ahammed, Z.; Ahmad, S.; Ahn, S.U.; Aiola, S.; Akindinov, A.; Al-Turany, M.; Alam, S.N.; Albuquerque, D.S.D.; Aleksandrov, D.; Alessandro, B.; Alfanda, H.M. Journal: Journal of instrumentation Issue: Volume 14:Number 5(2019) Page Start: P05025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of treatment of acute nonmalignant portal vein thrombosis with subcutaneous fondaparinux in patients with cirrhosis and marked thrombocytopenia. (10th February 2016) Authors: Tonon, M.; Piano, S.; Sacerdoti, D.; Dalla Valle, F.; Spiezia, L.; Bolognesi, M.; Simioni, P.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Final results of the "Global study". Issue 1 (February 2018) Authors: Piano, S.; Singh, V.; Caraceni, P.; Maiwall, R.; Alessandria, C.; Fernandez, J.; Soares, E.C.; Kim, D.J.; Kim, S.E.; Marino, M.; Vorobioff, J.; Barea, R. Ribeiro; Merli, M.; Elkrief, L.; Vargas, V.; Krag, A.; Singh, S.P.; Lesmana, L.A.; Toledo, C.; Marciano, S. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extracellular vesicles induce renal tubular cells apoptosis, oxidative stress and functional abnormalities in patients with an acute decompensation of cirrhosis. Issue 1 (16th February 2017) Authors: Brocca, A.; Medica, D.; Piano, S.; Romano, A.; Sticca, A.; Cantaluppi, V.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fondaparinux vs low molecular weight heparin in the treatment of non malignant portal vein thrombosis in patients cirrhosis. (February 2019) Authors: Senzolo, M.; Piano, S.; Sacerdoti, D.; Tonello, S.; Zanetto, A.; Tonon, M.; Simioni, P.; Bombonato, G.; Burra, P.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome. Issue 1 (16th February 2017) Authors: Piano, S.; Schmidt, H.; Ariza, X.; Amoros, A.; Romano, A.; Solà, E.; Gerbes, A.; Bernardi, M.; Alessandria, C.; Trebicka, J.; Gustot, T.; Nevens, F.; Arroyo, V.; Gines, P.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome. (February 2019) Authors: Vettore, E.; Piano, S.; Tonon, M.; Romano, A.; Gambino, C.; Bertoli, E.; Fasolato, S.; Zanus, G.; Boccagni, P.; Burra, P.; Cillo, U.; Angeli, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗